{
    "clinical_study": {
        "@rank": "102641", 
        "arm_group": [
            {
                "arm_group_label": "IPOI", 
                "arm_group_type": "Experimental", 
                "description": "One arm with pre-operative instillation 1h before TURB (IPOI : Instillation pr\u00e9-op\u00e9ratoire imm\u00e9diate),"
            }, 
            {
                "arm_group_label": "IPOP", 
                "arm_group_type": "Active Comparator", 
                "description": "One arm with early post-operative instillation within 24 hours (IPOP : Instillation Post Op\u00e9ratoire Pr\u00e9coce)."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this pilot study is to assess the efficacy and toxicity of immediate\n      pre-operative instillation of mitomycin C compared to the standard early post-operative ."
        }, 
        "brief_title": "Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer", 
        "condition": "Non Muscle-invasive Bladder Cancer", 
        "condition_browse": {
            "mesh_term": "Urinary Bladder Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years,\n\n          -  Primary or recurrent bladder tumor with endoscopic papillary aspect,\n\n          -  One or two bladder tumors,\n\n          -  Cytology before TURB showing no high-grade cells,\n\n          -  Patients without tutorship or subordination (ou curatorship),\n\n          -  Patients under the general social security system or qualifying through a third\n             party,\n\n          -  Informed consent signed by the patient after clear and fair information.\n\n        Exclusion Criteria:\n\n          -  Age < 18 years,\n\n          -  Allergy to mitomycin C,\n\n          -  Traumatic stenting,\n\n          -  Upper tract urothelial cancer,\n\n          -  Urethral invasion,\n\n          -  History of muscle invasive bladder cancer,\n\n          -  Extensive tumor (3 cm or more),\n\n          -  Any contraindication to TURB,\n\n          -  Simultaneous participation in another clinical research study,\n\n          -  Patients not insured by the social security or not qualifying through a third party,\n\n          -  Patients with enhanced protection, namely pregnant or lactating women, persons\n             deprived of their liberty by a judicial or administrative decision, people staying in\n             a health or social institution, adults under legal protection, and finally patients\n             in emergency situations,\n\n          -  Pregnant or lactating females or women of childbearing potential not willing to use\n             an adequate method of birth control for the duration of the study (i.e. hormonal /\n             mechanical contraceptive : oral, injectable, transdermal, implantable, intrauterine\n             or surgical device: tubal ligation, hysterectomy, total oophorectomy)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02075060", 
            "org_study_id": "IPOI vs IPOP"
        }, 
        "intervention": [
            {
                "arm_group_label": "IPOI", 
                "intervention_name": "IPOI (pre-operative)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "IPOP", 
                "intervention_name": "IPOP (post-operative)", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "low-grade", 
            "NMIBC"
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "contact": {
                "email": "jacques.irani@chu-poitiers.fr", 
                "last_name": "Jacques IRANI, MD, PhD", 
                "phone": "+33 (0)5.49.44.44.77"
            }, 
            "facility": {
                "address": {
                    "city": "Poitiers", 
                    "country": "France", 
                    "zip": "86100"
                }, 
                "name": "Poitiers University Hospital"
            }, 
            "investigator": {
                "last_name": "Jacques IRANI, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "jacques.irani@chu-poitiers.fr", 
            "last_name": "Jacques IRANI, MD, PhD", 
            "phone": ": +33 (0)5.49.44.44.77"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France : ANSM - French Health Products Safety Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "PFS", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02075060"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Poitiers University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Poitiers University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}